Comparison of activated partial thromboplastin time to activated clotting time for adequacy of heparin anticoagulation just before percutaneous transluminal coronary angioplasty. - Suppr | 超能文献

Comparison of activated partial thromboplastin time to activated clotting time for adequacy of heparin anticoagulation just before percutaneous transluminal coronary angioplasty.

作者信息

Grill H P, Spero J E, Granato J E

机构信息

Allegheny General Hospital, Cardiac Catheterization Laboratory, Pennsylvania.

出版信息

Am J Cardiol. 1993 May 15;71(13):1219-20. doi: 10.1016/0002-9149(93)90649-w.

DOI:10.1016/0002-9149(93)90649-w

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Comparison of activated partial thromboplastin time to activated clotting time for adequacy of heparin anticoagulation just before percutaneous transluminal coronary angioplasty.

Am J Cardiol. 1993 May 15;71(13):1219-20. doi: 10.1016/0002-9149(93)90649-w.

2

Comparison of activated clotting times to heparin management test for adequacy of heparin anticoagulation in percutaneous transluminal coronary angioplasty.

Cathet Cardiovasc Diagn. 1998 Nov;45(3):329-31. doi: 10.1002/(sici)1097-0304(199811)45:3<329::aid-ccd26>3.0.co;2-q.

3

Clinical safety and cost of heparin titration using bedside activated clotting time.使用床边活化凝血时间进行肝素滴定的临床安全性和成本

Am J Crit Care. 1993 Jan;2(1):81-7.

4

Monitoring anticoagulation following intracoronary procedures: which method?冠状动脉介入术后抗凝监测：采用哪种方法？

Int J Cardiol. 1994 Jun 15;45(2):103-8. doi: 10.1016/0167-5273(94)90264-x.

5

Preprocedural anticoagulation does not reduce angioplasty heparin requirements.术前抗凝并不能降低血管成形术时肝素的需求量。

Am Heart J. 1993 May;125(5 Pt 1):1221-5. doi: 10.1016/0002-8703(93)90988-l.

6

Heparin monitoring during coronary intervention: activated clotting time versus activated partial thromboplastin time.冠状动脉介入治疗期间的肝素监测：活化凝血时间与活化部分凝血活酶时间的比较

Can J Cardiol. 1993 Nov;9(9):797-801.

7

Heparin monitoring in the coronary care unit after percutaneous transluminal coronary angioplasty.

Heart Lung. 1990 May;19(3):265-70.

8

Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.在经皮腔内冠状动脉成形术期间及术后，通过测量活化凝血时间来监测肝素的效果。

Br Heart J. 1990 Jan;63(1):18-21. doi: 10.1136/hrt.63.1.18.

9

Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.重组水蛭素作为不稳定型心绞痛冠状动脉血管成形术中的围手术期抗栓药物。

Eur Heart J. 1996 Aug;17(8):1207-15. doi: 10.1093/oxfordjournals.eurheartj.a015038.

10

Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparin.接受大剂量肝素注射的冠状动脉血管成形术患者的活化凝血时间和活化部分凝血活酶时间。

Cathet Cardiovasc Diagn. 1992 Aug;26(4):260-3. doi: 10.1002/ccd.1810260404.

引用本文的文献

1

Activated clotting time or activated partial thromboplastin time as the method of choice for patients undergoing neuroradiological intervention.活化凝血时间或活化部分凝血活酶时间作为神经放射介入患者的首选方法。

Neuroradiology. 2003 May;45(5):325-7. doi: 10.1007/s00234-003-0975-3. Epub 2003 Mar 28.

2

Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.冠状动脉成形术后静脉注射肝素治疗期间的床边凝血测定法。

J Thromb Thrombolysis. 2001 Oct;12(2):157-63. doi: 10.1023/a:1012923505198.